palmitoylethanolamide.com.au
HomeResearchAlzbeta 2023

Distribution of an analgesic palmitoylethanolamide and other N-acylethanolamines in human placental membranes

Alzbeta Svobodova, Vladimir Vrkoslav, Ingrida Smeringaiova, Katerina Jirsova. PLoS One. 2023 Jan 13;18(1):e0279863.

Laboratory studyHumans

Design
Laboratory study
Subjects
Seven placentas collected after caesarean delivery
Dose used in the study
No palmitoylethanolamide was given; tissue levels were measured
Duration
Not stated in the abstract
What was measured
PEA, OEA and anandamide by liquid chromatography-mass spectrometry in amniotic and amniochorionic membranes, placental disc, umbilical cord, serum and vernix, before and after antibiotic decontamination.

What the authors reported

This laboratory study found:

  • N-acylethanolamines were present in all tissues, with palmitoylethanolamide the most abundant.
  • Mean PEA was highest in amniotic membrane (350.33 ± 239.26 ng/g).
  • OEA and anandamide were highest in placenta (219.08 and 30.06 ng/g respectively).
  • Antibiotic decontamination raised N-acylethanolamine levels in amniotic membrane 3.1 to 3.6-fold (P < 0.001) but not significantly in amniochorionic membrane.

Limits of this study

A tissue measurement study of seven placentas. It measured PEA content and did not test any effect of PEA in people. The authors declare no competing interests.

Source

PubMed 36638082 · doi:10.1371/journal.pone.0279863

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.